EMEA-001439-PIP01-13-M01

  • Email
  • Help

Overview

Product details for Exviera
Invented nameExviera
Active substance

Dasabuvir (sodium monohydrate)

Decision numberP/0066/2017
PIP numberEMEA-001439-PIP01-13-M01
Pharmaceutical form(s)Tablet; Age appropriate oral solid form
Condition(s)/indication(s)

Treatment of chronic hepatitis C

Route(s) of administrationOral use
PIP applicant

AbbVie Ltd
United Kingdom
E-mail: paediatricteam@abbvie.com
Tel. +44 (0)1628 644 475
Fax +44 (0)1628 672 549

Decision typePM: decision on the application for modification of an agreed PIP

Decision